FDA NDC Directory · JSON-LD · Markdown

Paclitaxel

NDC 0480-3290 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA216338
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · INTRAVENOUS
Active ingredientsPACLITAXEL (100 mg/20mL)
Marketing started20240702
Package count1

External sources

Source: openFDA. Public-domain (CC0).